Search Medical Condition
Please enter condition
Please choose location from dropdown

Stent Clinical Trials

A listing of Stent medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (213) clinical trials

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter was approved in the United States (US) under a Humanitarian Device Exemption (HDE) and received CE Mark in 2005. This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety surveillance requirements

Phase N/A

Cardiovascular disease is the leading cause of morbidity and mortality in industrialized nations, and atherosclerosis has been linked as the chief underlying pathology. Stroke as a result of the atherosclerotic carotid artery disease (CAD) is a common cause of death and a major reason for long-term disability worldwide1. Currently, it ...

Phase N/A

Multi center, non-blinded, non-randomized post approval study looking at the long-term performance of the Relay Thoracic Stent Graft System with Plus Delivery System by assessing the rate of aneurysm-related mortality at 5 years post-implant.

Phase N/A

Humanitarian Use for emergent, life-threatening free perforations, aka free contrast extravasations, into the pericardium in native coronary vessels or saphenous vein bypass grafts ≥ 2.75 mm in diameter.

Phase N/A

People with a wide-necked brain aneurysm are asked to participate in a research study being conducted by North Shore-Long Island Jewish Health System.

Phase N/A

Humanitarian Use Device - Intracranial artery stenosis - The WingspanTM Stent System and GatewayTM PTA Balloon Catheter have been developed for the treatment of intracranial artery stenosis. Patient Inclusion Criteria: Adults > 40 years old with symptomatic stenosis of one of those intracranial arteries: Internal carotid artery (ICA ), M1 ...

Phase N/A

A clinical study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System which was previously approved by the FDA. Patient Inclusion Criteria: >years of age Patients that need a stent in the coronary arteries Patient Exclusion Criteria: Cannot receive the protocol required dual antiplatelet therapy Currently taking warfarin or similar anticoagulant ...

Phase

Removal of the Evolution Esophageal Stent - Fully Covered

The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution Esophageal Stent-Fully Covered in malignant and benign indications.

Phase N/A

Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent

A Prospective, Multi-Center, Open Label, Randomized Controlled, two-arm Study to Evaluate the Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent 'Resolute Integrity' Compared to Polymer Free Amphilimus Eluting Stent 'Cre8'. Dual Antiplatelet Therapy duration of 1 Month will be applied in stable angina pectoris patient population. Myocardial infarction ...

Phase

DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT

DEDICATE Registry: DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT A POST MARKET REGISTRY OF ABLUMINUS SIROLIMUS ELUTING CORONARY STENT SYSTEM FOR PERCUTANEOUS INTERVENTION IN PATIENTS WITH DIABETES MELLITUS Version 1.0 Principal Investigator Dr. Luca Testa, MD, PhD Head of Coronary Revascularization Unit Head of Clinical Research ...

Phase N/A